Patents by Inventor Judith W. Zyskind

Judith W. Zyskind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6924101
    Abstract: A method for identifying endogenous microbial proliferation genes for growth and viability is disclosed herein. The method involves exogenous nucleic acids that are used to conditionally produce antisense inhibitors of endogenous complementary mRNAs in a microorganism. Antisense fragments that result in lethality when expressed indicate that the endogenous gene is a proliferation gene. The method can also be used with sequences in sense orientation. The strategy can be used to identify new gene targets for novel antibiotics.
    Type: Grant
    Filed: March 13, 2001
    Date of Patent: August 2, 2005
    Assignee: San Diego State University Foundation
    Inventors: Judith W. Zyskind, R. Allyn Forsyth
  • Patent number: 6838239
    Abstract: The present invention relates to reporter gene constructs encoding a cytoplasmic form of chitobiase (N,N?-diacetylchitobiase) and methods of using these reporter gene constructs. The use of a cytoplasmic form of chitobiase as a reporter enzyme is generally applicable to the study of gene expression in organisms which do not contain N-acetyl-?-D-glucosaminidases.
    Type: Grant
    Filed: August 2, 2000
    Date of Patent: January 4, 2005
    Assignee: San Diego State University Foundation
    Inventor: Judith W. Zyskind
  • Publication number: 20040029129
    Abstract: The sequences of antisense nucleic acids which inhibit the proliferation of prokaryotes are disclosed. Cell-based assays which employ the antisense nucleic acids to identify and develop antibiotics are also disclosed. The antisense nucleic acids can also be used to identify proteins required for proliferation, express these proteins or portions thereof, obtain antibodies capable of specifically binding to the expressed proteins, and to use those expressed proteins as a screen to isolate candidate molecules for rational drug discovery programs. The nucleic acids can also be used to screen for homologous nucleic acids that are required for proliferation in cells other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The nucleic acids of the present invention can also be used in various assay systems to screen for proliferation required genes in other organisms.
    Type: Application
    Filed: October 25, 2002
    Publication date: February 12, 2004
    Inventors: Liangsu Wang, Carlos Zamudio, Cheryl Malone, Robert Haselbeck, kari L. Ohlsen, Judith W. Zyskind, Daniel Wall, John D. Trawick, Grant J. Carr, Robert Yamamoto, R. Allyn Forsyth, H. Howard Xu
  • Publication number: 20030181408
    Abstract: The sequences of nucleic acids encoding proteins required for E. coli proliferation are disclosed. The nucleic acids can be used to express proteins or portions thereof, to obtain antibodies capable of specifically binding to the expressed proteins, and to use those expressed proteins as a screen to isolate candidate molecules for rational drug discovery programs. The nucleic acids can also be used to screen for homologous genes that are required for proliferation in microorganisms other than E. Coli. The nucleic acids can also be used to design expression vectors and secretion vectors. The nucleic acids of the present invention can also be used in various assay systems to screen for proliferation required genes in other organisms as well as to screen for antimicrobial agents.
    Type: Application
    Filed: October 31, 2002
    Publication date: September 25, 2003
    Inventors: R. Allyn Forsyth, Kari Ohlsen, Judith W. Zyskind
  • Patent number: 6620585
    Abstract: The present invention relates to methods of measuring cellular proliferation using ectoenzymes such as membrane-bound chitobiase (N,N′-diacetylchitobiase) and nucleic acids for use in such methods.
    Type: Grant
    Filed: August 2, 2000
    Date of Patent: September 16, 2003
    Assignee: Elitra Pharmaceuticals, Inc.
    Inventor: Judith W. Zyskind
  • Patent number: 6589738
    Abstract: The sequences of nucleic acids encoding proteins required for E. Coli proliferation are disclosed. The nucleic acids can be used to express proteins or portions thereof, to obtain antibodies capable of specifically binding to the expressed proteins, and to use those expressed proteins as a screen to isolate candidate molecules for rational drug discovery programs. The nucleic acids can also be used to screen for homologous genes that are required for proliferation in microorganisms other than E. Coli. The nucleic acids can also be used to design expression vectors and secretion vectors. The nucleic acids of the present invention can also be used in various assay systems to screen for proliferation required genes in other organisms as well as to screen for antimicrobial agents.
    Type: Grant
    Filed: November 9, 2000
    Date of Patent: July 8, 2003
    Assignee: Elitra Pharmaceuticals, Inc.
    Inventors: R. Allyn Forsyth, Kari Ohlsen, Judith W. Zyskind
  • Publication number: 20020061569
    Abstract: The sequences of antisense nucleic acids which inhibit the proliferation of prokaryotes are disclosed. Cell-based assays which employ the antisense nucleic acids to identify and develop antibiotics are also disclosed. The antisense nucleic acids can also be used to identify proteins required for proliferation, express these proteins or portions thereof, obtain antibodies capable of specifically binding to the expressed proteins, and to use those expressed proteins as a screen to isolate candidate molecules for rational drug discovery programs. The nucleic acids can also be used to screen for homologous nucleic acids that are required for proliferation in cells other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The nucleic acids of the present invention can also be used in various assay systems to screen for proliferation required genes in other organisms.
    Type: Application
    Filed: March 21, 2001
    Publication date: May 23, 2002
    Inventors: Robert Haselbeck, Kari L. Ohlsen, Judith W. Zyskind, Daniel Wall, John D. Trawick, Grant J. Carr, Robert T. Yamamoto, H. Howard Xu
  • Publication number: 20020058260
    Abstract: A method for identifying endogenous microbial proliferation genes for growth and viability is disclosed herein. The method involves exogenous nucleic acids that are used to conditionally produce antisense inhibitors of endogenous complementary mRNAs in a microorganism. Antisense fragments that result in lethality when expressed indicate that the endogenous gene is a proliferation gene. The method can also be used with sequences in sense orientation. The strategy can be used to identify new gene targets for novel antibiotics.
    Type: Application
    Filed: March 13, 2001
    Publication date: May 16, 2002
    Applicant: San Diego State University Foundation, California corporation
    Inventors: Judith W. Zyskind, R. Allyn Forsyth
  • Publication number: 20020022718
    Abstract: The sequences of nucleic acids encoding proteins required for E. coli proliferation are disclosed. The nucleic acids can also be used to screen for homologous genes that are required for proliferation in microorganisms other than E. coli. The nucleic acids can also be used to design expression vectors and secretion vectors. The nucleic acids can be used to express proteins or portions thereof, to obtain antibodies capable of specifically binding to the expressed proteins, and to use those expressed proteins as a screen to isolate candidate molecules for rational drug discovery programs. The nucleic acids of the present invention can also be used in various assay systems to screen for antimicrobial agents.
    Type: Application
    Filed: December 19, 2000
    Publication date: February 21, 2002
    Inventors: R. Allyn Forsyth, Kari L. Ohlsen, Judith W. Zyskind
  • Patent number: 6228579
    Abstract: A method for identifying endogenous microbial proliferation genes for growth and viability is disclosed herein. The method involves exogenous nucleic acids that are used to conditionally produce antisense inhibitors of endogenous complementary mRNAs in a microorganism. Antisense fragments that result in lethality when expressed indicate that the endogenous gene is a proliferation gene. The method can also be used with sequences in sense orientation. The strategy can be used to identify new gene targets for novel antibiotics.
    Type: Grant
    Filed: November 14, 1997
    Date of Patent: May 8, 2001
    Assignee: San Diego State University Foundation
    Inventors: Judith W. Zyskind, R. Allyn Forsyth